Other
Payment for (Proceeds from) Other Investing Activity
Gilead Sciences Payment for (Proceeds from) Other Investing Activity increased by 254.5% to $17.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.1%, from $23.00M to $17.00M. Over 2 years (FY 2021 to FY 2024), Payment for (Proceeds from) Other Investing Activity shows a downward trend with a 74.7% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026May 7, 2026
How to read this metric
Large fluctuations may indicate one-time events or non-recurring financial adjustments that require further investigation.
Detailed definition
Captures miscellaneous cash flows related to investing activities that do not fit into standard categories like capital...
Peer comparison
Often used as a catch-all category in cash flow statements across various sectors.
Metric ID:
other_payments_for_proceeds_from_other_investing_activitiesHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$91.00M | -$19.00M | $0.00 | $0.00 | $1.00M | $2.00M | $5.00M | $1.00M | -$6.00M | $1.00M | -$5.00M | -$7.00M | -$11.00M | -$35.00M | $23.00M | -$11.00M | $17.00M |
| QoQ Change | — | +79.1% | +100.0% | — | — | +100.0% | +150.0% | -80.0% | -700.0% | +116.7% | -600.0% | -40.0% | -57.1% | -218.2% | +165.7% | -147.8% | +254.5% |
| YoY Change | — | — | — | — | +101.1% | +110.5% | — | +0.0% | -400.0% | — | -200.0% | -800.0% | -83.3% | <-999% | +560.0% | +68.6% | -26.1% |
Range-$91.00M – $23.00M
CAGR-34.3%
Avg YoY Growth-388.1%
Median YoY Growth-26.1%
Payment for (Proceeds from) Other Investing Activity at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's payment for (proceeds from) other investing activity?
- Gilead Sciences (GILD) reported payment for (proceeds from) other investing activity of $17.00M in Q1 2026.
- How has Gilead Sciences's payment for (proceeds from) other investing activity changed year-over-year?
- Gilead Sciences's payment for (proceeds from) other investing activity decreased by 26.1% year-over-year, from $23.00M to $17.00M.
- What is the long-term trend for Gilead Sciences's payment for (proceeds from) other investing activity?
- Over 2 years (2021 to 2024), Gilead Sciences's payment for (proceeds from) other investing activity has grown at a 74.7% compound annual growth rate (CAGR), from -$19.00M to -$58.00M.
- What does payment for (proceeds from) other investing activity mean?
- Net cash flows from miscellaneous investing activities not classified elsewhere.